Mandate

Vinge advises Medivir on share redemption programme

November 26, 2014

Medivir AB (publ) (Nasdaq Stockholm) has resolved on a voluntary share redemption programme of SEK 625 million.

Vinge advises Medivir. The Vinge team primarily consists of Erik Sjöman (partner, capital markets & public M&A) and Rikard Lindahl.

Related

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026